Reviva Pharmaceuticals Holdings Inc. (RVPH) Stock: Analyzing the Market Value

1h ago, source: newsheater

The 36-month beta value for RVPH is at 0.04. Analysts have varying views on the stock, with 0 analysts rating it as a “buy,” 0 rating it as “overweight,” 0 as “hold,” and 0 as “sell.” The public float ...

RVPH Reviva Pharmaceuticals Holdings, Inc.

3d ago, source: Seeking Alpha

Reviva Pharmaceuticals Holdings, Inc., a clinical-stage biopharmaceutical company, discovers, develops, and commercializes next-generation therapeutics for diseases targeting unmet medical needs ...

RVPH: Update to Brilaroxazine Safety vs. Efficacy Comparison – Adding RECOVER Data

4d ago, source: Zacks Small Cap Research on MSN

RVPH Reviva Video Series Reviva Pharmaceuticals Holdings, Inc.’s (NASDAQ:RVPH) CEO Laxminarayan Bhat participated in a video ...

Reviva Pharmaceuticals Holdings, Inc. (RVPH)

23h ago, source: Investing

NEW YORK - Reviva Pharmaceuticals Holdings, Inc. has entered into an agreement for an at-the-market offering, announcing the sale of shares and warrants with a projected closing ...

Reviva Pharmaceuticals Holdings, Inc. (RVPH)

14d ago, source: Yahoo Finance

April 15, 2024 (GLOBE NEWSWIRE) -- Reviva Pharmaceuticals Holdings, Inc. (NASDAQ: RVPH), a late-stage pharmaceutical company developing therapies CUPERTINO, Calif., March 28, 2024 (GLOBE NEWSWIRE ...

Reviva Pharmaceuticals Holdings Inc Ordinary Shares

1mon ago, source: Morningstar

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Reviva Pharmaceuticals Holdings, Inc.

5mon ago, source: CNN

Reviva Pharmaceuticals Holdings, Inc. is a clinical-stage biopharmaceutical company, which engages in the discovery and development of therapeutics for the central nervous system, respiratory ...

Reviva Pharmaceuticals Holdings Inc.

5mon ago, source: Wall Street Journal

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

Reviva Pharmaceuticals Holdings Inc.

5mon ago, source: Barron's

Stocks: Real-time U.S. stock quotes reflect trades reported through Nasdaq only; comprehensive quotes and volume reflect trading in all markets and are delayed at least 15 minutes. International ...